- Home
- >
- All Countries
- >
- Qatar
Qatar Regulatory Compliance Consultant for Life Sciences
Comprehensive Regulatory Support From Product Strategy Through Commercialization and Post-Market Activities in the Life Sciences Industry.
Product Compliance and Local Approval Support in Qatar
The life sciences sector in Qatar is experiencing robust growth, driven by strategic government initiatives, increased healthcare spending, and a focus on innovation. Qatar’s healthcare industry is projected to reach $12 billion by 2025, with a Compound Annual Growth Rate (CAGR) of 5.1% through 2027. Specifically, the medical devices market is expected to grow at a CAGR of 5.7%, reaching QAR 1.1 billion (USD 298.6 million) by 2028, and the pharmaceuticals market is expected to cross USD 1 billion by 2028
We, at Artixio, are equipped to render customized regulatory services to suit the client’s needs and offer support throughout the product lifecycle.
Regulatory Authorities in Qatar
Ministry of Public Health (MOPH) – Qatar – Key departments within MOPH regulate various products, such as the Pharmacy and Drug Control Department is responsible for regulating pharmaceuticals, biological products, and herbal medicines, including overseeing product registration, import licensing, pricing, and pharmacovigilance; Medical Devices and Supplies Registration Office provides framework for registration of medical devices and equipment and ensures conformity to safety and performance standards.
Regulatory Process in Qatar
Pre-Registration
- Regulatory Intelligence & Strategy
- Product / Prioritization based on the Qatar Market
- Dossier Gap Analysis
- Technical Due Diligence
- Qatar Market Access Strategy
Registration
- Product Registration and Legal Representation
- Dossier Preparation for MOPH Submission
- Medical / Technical Writing Labeling and Artwork
- Review Preparation
- Health Authority Meetings and Liaison
- Audit Support
- eCTD/CTD Publishing and Submission
- Response to Queries / Approvals
- Compliance Analysis and Assessment
- QMS, Mock Audits & Vendor Audits
- Pricing & Reimbursement
Post-Registration
- Product Lifecycle Maintenance
- Artwork / Label / Ad-promo Reviews as per EMA guidelines
- Line Extensions
- Response to EMA Regulatory / Safety Queries Distribution / Import Assistance
- Qatar Compliance monitoring
- Post-marketing Surveillance
- Product Recall & Change Management
- Advertisement & Promotional Material Review
Why Us For Regulatory Consulting Services in Qatar?
ISO 9001:2015 certified company.
Strong Regional Presence and 15- 35 years of Regulatory Experience
AI-driven global regulatory services supported by QuriousRI
200+ Successful Product Approvals and Ongoing Product Lifecycle Maintenance
Diverse Experience across Complex Product Categories and Therapeutic Areas
FAQs
Is Qatar part of any regional regulatory harmonization initiatives?
Yes, Qatar is part of the Gulf Health Council (GHC), which coordinates the centralized pharmaceutical product registration system for GCC countries.
Are there fast-track or priority review pathways for innovative products?
Qatar does not currently have a formal “priority review” pathway published, but in practice, Products addressing unmet medical needs (e.g., oncology, rare diseases, COVID-19-related) are often reviewed more quickly.
What regulatory risks should be considered before entering the Qatar market?
Local sponsor requirements are applicable for foreign firms, and evolving regulatory policies that the companies must adhere to.
What are the strategic benefits of registering life science products in Qatar?
Access to a rapidly growing healthcare market; Gateway to the GCC region; Strong government backing and incentives for healthcare innovation, precision medicine, and biopharma investments.
Artixio addresses these challenges by providing flexible, budget friendly and timely compliance solutions and regulatory affairs services using global standards for seamless projects delivery, secure information exchange, high quality services, regional expertise and network and systems driven processes.
What regulatory trends are likely to impact our medium- to long-term planning in Qatar?
Trends such as a shift toward digital health regulation, increased post-market surveillance obligations, and privatization and PPP growth in healthcare delivery.
Our Services
Regulatory Affairs
Product Registration
Market Access
IND (Investigational New Drug)
NDA (New Drug Application)
Regulatory Operations
Technical Writing
Regulatory Strategy
Market Access
Industries We Serve in the Qatar
Pharmaceuticals
MedTech
Cosmetics
Nutrition
Biologics
Veterinary
Our Global Reach: Serving Life Sciences Clients Worldwide
India
Singapore
Mexico
Brazil
Vietnam
Malaysia
Argentina
Colombia
Taiwan
China
Europe
Thailand
Indonesia
Philippines
USA
Japan
Qatar
South Korea
Insights from Artixio - Tips & Articles
AI Solutions For Pharma
As the technology is reaching its heights, new innovations like AI can serve the...
Thai FDA Updates Medical
The Food and Drug Administration Announcement RE: Determination of Criteria, Conditions, and Requirements for...
In Vitro Companion Diagnostics
A Companion Diagnostic (CDx) is an in-vitro diagnostic (IVD) medical device that plays a...